← Back to Discover
LETKO, BROSSEAU & ASSOCIATES INC
Period ended Sep 30, 2026 · Latest filing Nov 6, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2026: $6,899,112,169
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- MANULIFE FINL CORP · COM · 56501R106 · shares: $254,720,333
- BANK NOVA SCOTIA B C · COM · 064149107 · shares: $253,054,681
- SUN LIFE FINANCIAL INC. · COM · 866796105 · shares: $241,635,441
- ALPHABET INC · CAP STK CL C · 02079K107 · shares: $228,731,940
- TORONTO DOMINION BK ONT · COM NEW · 891160509 · shares: $226,611,197
- MAGNA INTL INC · COM · 559222401 · shares: $222,784,286
- ILLUMINA INC · COM · 452327109 · shares: $219,995,744
- ROYAL BK CDA · COM · 780087102 · shares: $214,944,232
- META PLATFORMS INC · CL A · 30303M102 · shares: $205,735,014
- ROGERS COMMUNICATIONS INC · CL B · 775109200 · shares: $200,814,799
Reported holdings
108 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| CABALETTA BIO INC | COM | 12674W109 | — | 90,475 shares | $173,712 |
| ARS PHARMACEUTICALS INC | COM | 82835W108 | — | 40,050 shares | $172,616 |
| AQUESTIVE THERAPEUTICS INC | COM | 03843E104 | — | 35,325 shares | $163,555 |
| TSCAN THERAPEUTICS INC | COM | 89854M101 | — | 95,875 shares | $30,153 |
| PROKIDNEY CORP | SHS CL A | 74291D104 | — | 15,900 shares | $26,394 |
| HUMACYTE INC | COM | 44486Q103 | — | 45,950 shares | $23,788 |
| ALDEYRA THERAPEUTICS INC | COM | 01438T106 | — | 17,300 shares | $21,279 |
| TENAX THERAPEUTICS INC | COM NEW | 88032L605 | — | 10,650 shares | $20,129 |